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ABSTRACT                        Bilirubin is regarded as the most powerful endogenous antioxidant substance.
It exhibits immunmodulator, inhibitor activities on kinases, yet it is clear that it can be
potentially cytotoxic. Gilbert syndrome is characterised by hereditary, chronic, mild unconjugat-
ed hyperbilirubinaemia. 12 Gilbert syndrome patients and 15 healthy controls were investigat-
ed with special regard to reduction-oxidation status and free radical-antioxidant balance. Sera
free SH-group concentration, H-donating ability, reducing power were measured spec-
trophotometric methods. Total scavenger capacity, describing free radical-antioxidant balance,
was determined by a newly developed chemiluminometric method in sera, plasma and
erythrocytes. Patients with Gilbert syndrome showed a significant increase of non-enzymatic
antioxidant capacity. Elevated free SH-group concentration, H-donating ability and reducing
power were found in mild hyperbilirubinaemia compared with control group patients. On the
other hand no significant differences were detected regarding free radical-antioxidant balance
in sera, plasma and erythrocytes between the groups. On the basis of these results it can be
supposed that elevated bilirubin concentration, via indirect or compensatory way, strengthens
non-enzymatic antioxidant capacity, without changes in antioxidant-free radical balance. That
is why further investigations are needed to clarify the consequences of elevated bilirubin
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Gilbert syndrome is a chronic non-hemolytic unconjugated
hyperbilirubinaemia, occuring in the absence of liver disease
or overt haemolysis and characterised by episodes of mild
intermittent jaundice. It is the most common inherited
disorder of hepatic bilirubin metabolism, occuring of 2-12
percent of the general population. Gilbert syndrome is caused
by a reduction in the activity of hepatic bilirubin UDP-
glucuronosyl-transferase (UGT1A1) to about 30 percent of
normal. The reduction of this gene activity has been shown
due to a polymorphism in the promoter region of the
UGT1A1 gene, the presence of superfluous thyamin adenine
repeats reduces the efficiency of transcription of this gene.
The rarer, more severe and dominantly inherited forms
identified to date are heterozygosity for a nonsense mutations
in the coding region of the UGT1 gene (Bosma et al. 1995;
Monaghan et al. 1996; Beutler et al. 1998).
UGT1A1 polymorphism is suggested that may provide a
flexible polymorphism that maintain bilirubin levels in a
range high enough to protect against oxidative stress, but not
so high as to cause a high incidence of kernicterus (Beutler
et al. 1998). Bilirubin exhibits intriguing biological activities
as an antioxidant, an antimutagen and an anti-complement
agent. Some authors suggest that neonatal hyperbiliru-
binaemia could be a transitional antioxidative mech-anism in
the circulation of human neonates (Marilena 1997). Antiox-
idant property of bilirubin is seemed to be responsible for the
reduced risk of coronary artery disease in Gilbert syndrome
(Vitek et al. 2002).
Materials and Methods
We studied the redox status and free radical-antioxidant
balance in 12 Caucasians patients with Gilbert syndrome,
ranging from 18 to 52 years (mean±SEM: 27.08±2.73 years;
11 male, 1 female), in whom the syndrome was clinically
diagnosed based on a consistent mildly raised non-fasting
serum total bilirubin concentration (range: 25-59 µmol/l) and
on the absence of structural liver disease proved by utra-
sonography. Serum alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) values were normal (range
ALT: 11-40 U/l; AST: 15-27 U/l). Hemolysis was excluded
on the basis of normal hemoglobin value and reticulocyte
counts. 16 Caucasians healthy subjects were examined (age:
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27.42±2.35 years; 8 male, 4 female) with no known history
of jaundice and with normal serum total bilirubin concen-
tration. (In our laboratory the upper limit of normal for serum
total bilirubin concentration is 25 µmol/l. Normal values for
AST: 10.00-37.00 U/l; ALT: 5.00-40.00 U/l; GGT: 7.00-
50.00 U/l; ALP: 98.00-279.00 U/l)
The study was approved by the Regional Committee of
Science and Research Ethics, Semmelweis University (per-
mission number: TUKEB 186/1998). Informed consent was
obtained from all subjects. Authors ensure that their work
complies with the Declaration of Helsinki (1964).
Plasma and erythrocytes were separated with routine
methods and the haemoglobin contents of samples were
adjusted to 10 g/l for measurements for Haemisol reagent.
The reducing power of the samples were determined at 700
nm according to the method of Oyaizu (1986), based on the
chemical reaction Fe (III) → Fe(II). Increased absorbance
indicated greater reducing power, which was expressed as the
ascorbic acid equivalent (mmol/leqAS). The hydrogen-
donating ability of the samples was estimated in the presence
of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical at 517 nm
on the basis of the method of Hatano et al. (1988). DPPH
stable radical was found to oxidise cysteine, glutathione,
ascorbic acid, tocopherol, polyhydroxy aromatic compounds
and aromatic amines. Plasma free SH-group concentrations
were measured by the Sedlak and Lindsay (1968) method.
The total scavenger capacity (TSC) was determined in
plasma, sera and erythrocytes by a chemiluminescence assay
with Berthold Lumat 9501 manual luminometer, in H2O2/
OH.--luminol-microperoxidase system to assess the antiox-
idant capacity and free radicalantioxidant balance. This
luminometer is designed to determine single photons of light
emitted in the course of a chemical reaction between luminol
and free radicals. Intensity of the standard light of H2O2/OH.-
luminol-microperoxidase system changes depending on the
antioxidant-free radical balance in the biological sample and
expressed as the percentage of the standard light (RLU%=
relative Light Unit%). Higher chemiluminometric intensity
indicates lower total scavenger capacity (Blázovics et al.
1999).
1,1-diphenyl-2-picrylhydrazyl, 5,5'-dithiobis-2-nitroben-
zoic acid, luminol, microperoxidase were obtained from
Sigma (St. Louis, USA). Haemsiol reagent was bought from
Human Oltóanyag (Gödöllô, Hungary). All other reagents
were purchased from Reanal (Budapest, Hungary).
One-way ANOVA statistical analysis was used to evaluate
the significance between patient groups. Data are expressed
as mean±SEM. P<0.05 was considered to indicate statistical
significance.
Results
Total bilirubin concentration in sera showed a significant
increase in patients with Gilbert syndrome compared to
control group (36.67±2.37 vs. 8.50±0.87 µmol/l). Liver
enzymes activities were slightly elevated in hyper-
bilirubinemic patients, however they did not exceed normal
values (Table 1). Significantly elevated H-donating ability
(50.68±0.97 vs. 46.11±1.10%), reducing power
(1.599±0.004 vs. 1.322±0.088 nmol/leqAS) and free SH-
group concentration (0.35±0.009 vs. 0.43±0.013 mmol/l)
could be observed in Gilbert syndrome compared to that of
control subjects (Table 2). On the other hand no significant
differences were observed regarding total scavenger capacity
of plasma, sera as well as erythrocytes between healthy
controls and Gilbert syndrome patients (Table 3). Bilirubin
concentration showed significant correlation only with
reducing power (R2=0.4080, P=0.0253). No significant
relation was found in connection with free SH-group concen-
tration (R2=0.0012, P=0.9142), H-donating ability
(R2=0.2509, P=0.0971) and total scavenger capacity
(R2=0.0655, P=0.4217).
Table 1. Routine laboratory parameters in Gilbert syndrome and control patients.
Total bilirubin
concentration (µmol/l) AST (U/l) ALT (U/l) GGT (U/l) ALP (U/l)
Healthy controls 8.50±0.87 17.00±1.35 15.75±2.21 18.00±5.30 157.53±39.43
Patients with Gilbert syndrome 36.67±2.37 23.17±1.14 28.33±4.50 21.83±3.27 194.83±18.11
Table 2. Non-enzymatic antioxidant capacity of sera.
H-donating ability Reducing power property Free SH-group
concentration
(%) (nmol/leqAS) (mmol/l)
Healthy controls 46.11±1.10 264.43±17.59 0.35±0.009
Patients with Gilbert syndrome 50.68±0.97* 319.90±8.08* 0.43±0.013*
*sign. (P<0.05) vs. control group
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Discussion
Bilirubin (conjugated/non-bound, non-conjugated/albu-
minbound) is regarded as a member of the antioxidant family,
even though it is known to have toxic effects at high concen-
trations. Bilirubin could be an important cytoprotector for
tissues which are less equipped for antioxidant defence like
myocardium and nervous tissues (Marilena 1997). Along
with ascorbate and urate, this bile pigment is a very important
antioxidant in plasma, can act synergistically with vitamin E
in protecting lipid membranes from peroxidation initiated
within the lipid phase (Stocker et al.1990; Marilena 1997).
Bilirubin is a potent scavenger of singlet oxygen and
peroxyl radicals with high efficiency by initial donation of
a hydrogen atom of the tetrapyrrole ring (Stocker et al. 1990;
Dudnik and Khrapova 1998; Minetti et al. 1998; Yesilkaya
et al. 1998). Bilirubin does react with superoxide anion to
some extent and serves as a substrate for peroxidases in the
presence of hydrogen peroxide or organic hydroperoxides
(Stocker et al. 1987). The superoxide scavenger activity
similar to that of serum albumin, higher than the vitamin E
analog Trolox and lower than ascorbic acid (Marilena 1997).
Bilirubin participates as a scavenger of secondary oxidants
formed in the oxidative process (Minetti et al. 1998). Addi-
tion of bilirubin to erythrocytes incubated with cumeneOOH
(shows a similar effect to the other organic hydroperoxides
and produces alkoxyl and peroxyl radicals) induced an
inhibition in lipid peroxidation processes, preserving SOD
activity, increasing catalase and glucose-6-phosphate
dehydrogenase activity and reduced glutathione concen-
tration (Yesilkaya et al. 1998).
Bilirubin also possess antimutagenic properties and
conjugated bilirubin shows an inhibitory effect on com-
plement dependent reactions in vitro, blocking complement
cascade, especially at the C1 step (Marilena et al. 1998).
It is clear that bilirubin can be toxic to cells at higher
concentrations (>30 mg/dl; Mireles et al. 1999). Bilirubin
caused cytotoxicity is amplified by TNF-alfa and endotoxin.
These results provide a supportive evidence that sepsis would
increase the risk of tissue damage by bilirubin, the sepsis may
enhance the risk of kerinicterus (Ngai and Yeung 1999). It has
been recently reported that bilirubin forms a complex with
Cu(II), which results in the reduction of Cu(II) to Cu(I) and
this redox cycle gives rise to the formation of reactive oxygen
species, particularly hydroxyl radical causing DNA breakage
(Asad et al. 1999). It was deduced that bilirubin free radical
initiates and promotes the pigment gallstone formation.
Bilirubin free radicals were detected by electron spin reso-
nance. The main target of bilirubin free radical is the cell
membrane and membrane bound protein (Blázovics et al.
1997; Liu and Hu 2002).
Bilirubin is also a potent immunomodulator: inhibits
responses of human lymphocytes, including phytohemag-
glutinin- induced proliferation, interleukin-2 production and
antiobody dependent and independent cell-mediated cytotox-
icity (Haga et al. 1996, Maines et al. 1999). This observation
may explain the increased susceptibility to infection observed
in hyperbilirubinemic patients (Haga et al. 1996). Bilirubin
can inhibit protein kinases (cAMP-dependent, cGMP-
dependent, Ca2+-calmodulin-dependent Ca2+-phospho-lipid
dependent) by a non-competative mechanism, mod-ulating
the protein phosphorilation in cellular regulation contributed
to its neurotoxicity (Hansen et al. 1996). This kinases initiate
and regulate various signal transduction processes including
those involved in cell proliferation (Maines et al. 1999).
Earlier studies presumed that elevated bilirubin concen-
tration in Gilbert syndrome serve as an increased antioxidant
capacity (Vitek et al. 2002). The object of this study was to
investigate the redox status, the free radical antioxidant
balance in Gilbert syndrome patients by newly applicated
spectrophotometric and newly developed luminometric
methods. The mild hyperbilirubinaemia caused elevated SH-
group concentration, H-donating ability and reducing power
in sera. There were no significant correlations between
bilirubin concentration and free SH group concentration as
well as H-donating ability. On the other hand strong relation
was found between bilirubinaemia and reducing power. On
the basis of literature we give the following explanations for
our results. Bilirubin may reduce – in consequence its
antioxidant property – the utilisation of the free SH group and
other antioxidant compounds and molecules, and therefore
reinforce antioxidant capacity of tissues. Then again,
strengthened antioxidant capacity caused by the mild hyper-
bilirubinaemia may be in connection with a compensatory
mechanism against toxic bilirubin.
On the other hand a shift of free radical–antioxidant
balance was not proved by our chemiluminometric mesaure-
ments. We did not detect any significant differences between
Gilbert syndrome and healthy control patients in sera, plasma
and erythrocytes and tendency was not observed as well. On
the basis of these results it can be supposed that elevated
bilirubin concentration, via indirect or compensatory way,
strengthens non-enzymatic antioxidant capacity, without
changes in antioxidant-free radical balance. Further studies
Table 3. Total scavenger capacity of sera, plasma and erythrocytes.
Sera (RLU%) Plasma (RLU%) Erythrocytes (RLU%)
Healthy controls 20.41±1.61 1.42±0.16 54.11±4.63
Patients with Gilbert syndrome 17.59±1.94 1.44±0.24 55.94±1.76
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are needed to investigate the consequences of elevated
bilirubin concentration in cell redox homeostasis, on the
ground its free SH-group concentration elevating, H-donating
and reducing power.
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